LONDON, March 14 (Reuters) – AstraZeneca is looking at ways to link pay for Chief Executive Pascal Soriot and other top managers more directly to the drugmaker’s target of achieving revenue of $45…
The post AstraZeneca weighs linking CEO pay more closely to sales target appeared first on NASDAQ.